# Trancura Biosciences, Inc. — Form D

Trancura Biosciences, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-07. The offering totals $972K, of which $972K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-01-07
- Form: D
- Accession: 0001902650-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $972K
- Amount sold: $972K
- Investors: 3
- Date of first sale: 2021-12-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-428315

## Issuer

- Name: Trancura Biosciences, Inc.
- CIK: 0001902650
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1555 PARK AVENUE, EMERYVILLE, CA, 94608
- Phone: 510-225-8366

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Francisco Herrera | Director | Emeryville, CA |
| Pablo D Valenzuela | Director | Emeryville, CA |
| Francisco Herrera | Executive Officer | Emeryville, CA |
| Luis F Larrondo | Executive Officer | Emeryville, CA |

## More

- [CIK 1902650 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1902650&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001902650-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.